|[November 19, 2012]
Square 1 Financial, Inc. Announces Dr. Seth Rudnick Has Joined the Board of Directors
DURHAM, N.C. --(Business Wire)--
Square 1 Financial, Inc. is pleased to announce that Dr. Seth Rudnick
has joined the Board of Directors of both Square 1 Financial, Inc. and Square
1 Bank. Dr. Rudnick has an extensive background in the venture
capital industry, as well as over 30 years of comprehensive experience
in the biotechnology, healthcare and pharmaceutical industries.
Dr. Rudnick is currently a Partner at Canaan
Partners, a global venture capital firm, where he leads the firm's
investments in healthcare companies. His prior leadership experience
also includes the roles of Chairman of the Board and CEO at
CytoTherapeutics, a company focused on the development and
commercialization of stem-cell based therapies, and Senior Vice
President of Biotech Research and Development at R.W. Johnson
Pharmaceutical Research Institute, where he led all research and
development activities and managed the Institut's Biotechnology Center
in San Diego, California.
Dr. Rudnick also currently serves as a board member of Liquidia
Technologies, ORTHOCON, Pozen, Spine Wave and Vaxinnate. He is a member
of the Chimerix Scientific Advisory Board, and is an adjunct clinical
professor of medicine at The University of North Carolina at Chapel Hill.
"We are excited to welcome Seth as a Director of Square 1 Bank and
Square 1 Financial. He brings considerable experience and insight,
shares the strategic vision of our organization, and his background
closely parallels the Bank's core business model. Seth's immersion and
his considerable experience in life sciences investments, makes him an
invaluable addition and resource for our team," said Doug Bowers,
Chairman, President and Chief Executive Officer of Square 1 Bank.
"I have been delighted by Square 1's nationwide efforts in the life
sciences space," said Dr. Rudnick. "I am excited to join the board of
such a high-quality, innovative financial institution, especially one
headquartered in my home state of North Carolina. I look forward to
working with other members of the board and management to accelerate
Square 1's success in serving entrepreneurs and the venture capital
community in all stages of growth."
Dr. Rudnick received his M.D. from the University of Virginia and a B.A.
in History from the University of Pennsylvania. He was a Yale University
Fellow in medical oncology, where he was a Robert Wood Johnson Clinical
Scholar, and has twice been named to the Midas List, a ranking of
leading venture capitalists in the technology and life sciences
About Square 1 Financial
Square 1 Financial, Inc. is the bank holding company for Square 1 Bank,
a full service commercial bank dedicated exclusively to serving the
financial needs of the venture capital community and entrepreneurs in
all stages of growth and expansion. Square 1's expertise, focus and
strong capital base provide flexible resources and unmatched support to
meet our clients' needs. The bank offers tailored products and solutions
aided by the latest in technological innovations. Square 1 has offices
coast to coast in Austin, Boston, Denver, Durham, Los Angeles, New York,
San Diego, Seattle, Silicon Valley and Washington, DC. For more
information, visit www.square1bank.com.
[ Back To TMCnet.com's Homepage ]